Epidemiology and natural history of hepatitis C infections in liver transplant recipients

J. S. Weinstein, J. J. Poterucha, N. Zein, R. H. Wiesner, D. H. Persing, Jorge Rakela

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Hepatitis C infection is common in patients undergoing liver transplantation. Few studies have focused on the prevalence and epidemiology of hepatitis C infection among liver transplant recipients since the implementation of donor screening for antibodies against the hepatitis C virus (anti-HCV). Using reverse transcription-polymerase chain reaction (RT-PCR) and genomic sequencing methods, we sought to determine the prevalence, epidemiology, and natural history of hepatitis C infections among 44 consecutive liver transplant patients between January and December 1991. All patients and donors were screened for antibodies against HCV with a first-generation test. Laboratory tests and liver biopsies were routinely done 12 months after transplantation. Serum samples from all organ donors and transplant recipients were analyzed for the presence of HCV-RNA. From four of the six HCV-RNA-positive patients, pre- and post-transplant serum samples were available for sequence analysis. No donor had detectable HCV-RNA. Six of 44 (13.6%) patients had detectable HCV-RNA before and after liver transplantation. Recurrent infection was documented in all who were infected before transplantation and was confirmed by genotype analysis in the four patients who were analyzed. No acquired infections were identified. After transplantation, the HCV-RNA-positive recipients had higher mean alanine aminotransferase (207±85 U/l vs 37±7 U/l; p<0.0001) and were more likely to have chronic hepatitis (50% vs 6%; p<0.03) than the HCV-RNA-negative recipients. We conclude that hepatitis C infections are not uncommon in the setting of liver transplantation, recurrent infections are practically universal after transplantation, and when donors are screened for antibodies against HCV, acquired infections are rare. The histologic changes associated with hepatitis C infections in liver transplant recipients are variable but tend to be mild. Future studies must assess the long-term effects of hepatitis C in liver transplant recipients and establish the appropriate use of organs from donors with detectable antibodies against HCV.

Original languageEnglish (US)
Pages (from-to)154-159
Number of pages6
JournalJournal of Hepatology, Supplement
Volume22
Issue number1
StatePublished - 1995

Fingerprint

Hepatitis C
Epidemiology
Liver
Hepatitis C Antibodies
Infection
RNA
Tissue Donors
Transplantation
Liver Transplantation
Transplants
Transplant Recipients
Donor Selection
Chronic Hepatitis
Serum
Alanine Transaminase
Reverse Transcription
Sequence Analysis
Genotype
Biopsy
Polymerase Chain Reaction

Keywords

  • Chronic hepatitis
  • Donor screening
  • HCV-RNA
  • Hepatitis C
  • Liver transplantation
  • Viral genotypes
  • Viral transmission

ASJC Scopus subject areas

  • Hepatology

Cite this

Weinstein, J. S., Poterucha, J. J., Zein, N., Wiesner, R. H., Persing, D. H., & Rakela, J. (1995). Epidemiology and natural history of hepatitis C infections in liver transplant recipients. Journal of Hepatology, Supplement, 22(1), 154-159.

Epidemiology and natural history of hepatitis C infections in liver transplant recipients. / Weinstein, J. S.; Poterucha, J. J.; Zein, N.; Wiesner, R. H.; Persing, D. H.; Rakela, Jorge.

In: Journal of Hepatology, Supplement, Vol. 22, No. 1, 1995, p. 154-159.

Research output: Contribution to journalArticle

Weinstein, JS, Poterucha, JJ, Zein, N, Wiesner, RH, Persing, DH & Rakela, J 1995, 'Epidemiology and natural history of hepatitis C infections in liver transplant recipients', Journal of Hepatology, Supplement, vol. 22, no. 1, pp. 154-159.
Weinstein, J. S. ; Poterucha, J. J. ; Zein, N. ; Wiesner, R. H. ; Persing, D. H. ; Rakela, Jorge. / Epidemiology and natural history of hepatitis C infections in liver transplant recipients. In: Journal of Hepatology, Supplement. 1995 ; Vol. 22, No. 1. pp. 154-159.
@article{1c2cdb4f730e4220bb5cd4af9a3eb0d5,
title = "Epidemiology and natural history of hepatitis C infections in liver transplant recipients",
abstract = "Hepatitis C infection is common in patients undergoing liver transplantation. Few studies have focused on the prevalence and epidemiology of hepatitis C infection among liver transplant recipients since the implementation of donor screening for antibodies against the hepatitis C virus (anti-HCV). Using reverse transcription-polymerase chain reaction (RT-PCR) and genomic sequencing methods, we sought to determine the prevalence, epidemiology, and natural history of hepatitis C infections among 44 consecutive liver transplant patients between January and December 1991. All patients and donors were screened for antibodies against HCV with a first-generation test. Laboratory tests and liver biopsies were routinely done 12 months after transplantation. Serum samples from all organ donors and transplant recipients were analyzed for the presence of HCV-RNA. From four of the six HCV-RNA-positive patients, pre- and post-transplant serum samples were available for sequence analysis. No donor had detectable HCV-RNA. Six of 44 (13.6{\%}) patients had detectable HCV-RNA before and after liver transplantation. Recurrent infection was documented in all who were infected before transplantation and was confirmed by genotype analysis in the four patients who were analyzed. No acquired infections were identified. After transplantation, the HCV-RNA-positive recipients had higher mean alanine aminotransferase (207±85 U/l vs 37±7 U/l; p<0.0001) and were more likely to have chronic hepatitis (50{\%} vs 6{\%}; p<0.03) than the HCV-RNA-negative recipients. We conclude that hepatitis C infections are not uncommon in the setting of liver transplantation, recurrent infections are practically universal after transplantation, and when donors are screened for antibodies against HCV, acquired infections are rare. The histologic changes associated with hepatitis C infections in liver transplant recipients are variable but tend to be mild. Future studies must assess the long-term effects of hepatitis C in liver transplant recipients and establish the appropriate use of organs from donors with detectable antibodies against HCV.",
keywords = "Chronic hepatitis, Donor screening, HCV-RNA, Hepatitis C, Liver transplantation, Viral genotypes, Viral transmission",
author = "Weinstein, {J. S.} and Poterucha, {J. J.} and N. Zein and Wiesner, {R. H.} and Persing, {D. H.} and Jorge Rakela",
year = "1995",
language = "English (US)",
volume = "22",
pages = "154--159",
journal = "Journal of Hepatology, Supplement",
issn = "0169-5185",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Epidemiology and natural history of hepatitis C infections in liver transplant recipients

AU - Weinstein, J. S.

AU - Poterucha, J. J.

AU - Zein, N.

AU - Wiesner, R. H.

AU - Persing, D. H.

AU - Rakela, Jorge

PY - 1995

Y1 - 1995

N2 - Hepatitis C infection is common in patients undergoing liver transplantation. Few studies have focused on the prevalence and epidemiology of hepatitis C infection among liver transplant recipients since the implementation of donor screening for antibodies against the hepatitis C virus (anti-HCV). Using reverse transcription-polymerase chain reaction (RT-PCR) and genomic sequencing methods, we sought to determine the prevalence, epidemiology, and natural history of hepatitis C infections among 44 consecutive liver transplant patients between January and December 1991. All patients and donors were screened for antibodies against HCV with a first-generation test. Laboratory tests and liver biopsies were routinely done 12 months after transplantation. Serum samples from all organ donors and transplant recipients were analyzed for the presence of HCV-RNA. From four of the six HCV-RNA-positive patients, pre- and post-transplant serum samples were available for sequence analysis. No donor had detectable HCV-RNA. Six of 44 (13.6%) patients had detectable HCV-RNA before and after liver transplantation. Recurrent infection was documented in all who were infected before transplantation and was confirmed by genotype analysis in the four patients who were analyzed. No acquired infections were identified. After transplantation, the HCV-RNA-positive recipients had higher mean alanine aminotransferase (207±85 U/l vs 37±7 U/l; p<0.0001) and were more likely to have chronic hepatitis (50% vs 6%; p<0.03) than the HCV-RNA-negative recipients. We conclude that hepatitis C infections are not uncommon in the setting of liver transplantation, recurrent infections are practically universal after transplantation, and when donors are screened for antibodies against HCV, acquired infections are rare. The histologic changes associated with hepatitis C infections in liver transplant recipients are variable but tend to be mild. Future studies must assess the long-term effects of hepatitis C in liver transplant recipients and establish the appropriate use of organs from donors with detectable antibodies against HCV.

AB - Hepatitis C infection is common in patients undergoing liver transplantation. Few studies have focused on the prevalence and epidemiology of hepatitis C infection among liver transplant recipients since the implementation of donor screening for antibodies against the hepatitis C virus (anti-HCV). Using reverse transcription-polymerase chain reaction (RT-PCR) and genomic sequencing methods, we sought to determine the prevalence, epidemiology, and natural history of hepatitis C infections among 44 consecutive liver transplant patients between January and December 1991. All patients and donors were screened for antibodies against HCV with a first-generation test. Laboratory tests and liver biopsies were routinely done 12 months after transplantation. Serum samples from all organ donors and transplant recipients were analyzed for the presence of HCV-RNA. From four of the six HCV-RNA-positive patients, pre- and post-transplant serum samples were available for sequence analysis. No donor had detectable HCV-RNA. Six of 44 (13.6%) patients had detectable HCV-RNA before and after liver transplantation. Recurrent infection was documented in all who were infected before transplantation and was confirmed by genotype analysis in the four patients who were analyzed. No acquired infections were identified. After transplantation, the HCV-RNA-positive recipients had higher mean alanine aminotransferase (207±85 U/l vs 37±7 U/l; p<0.0001) and were more likely to have chronic hepatitis (50% vs 6%; p<0.03) than the HCV-RNA-negative recipients. We conclude that hepatitis C infections are not uncommon in the setting of liver transplantation, recurrent infections are practically universal after transplantation, and when donors are screened for antibodies against HCV, acquired infections are rare. The histologic changes associated with hepatitis C infections in liver transplant recipients are variable but tend to be mild. Future studies must assess the long-term effects of hepatitis C in liver transplant recipients and establish the appropriate use of organs from donors with detectable antibodies against HCV.

KW - Chronic hepatitis

KW - Donor screening

KW - HCV-RNA

KW - Hepatitis C

KW - Liver transplantation

KW - Viral genotypes

KW - Viral transmission

UR - http://www.scopus.com/inward/record.url?scp=0028969272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028969272&partnerID=8YFLogxK

M3 - Article

C2 - 7602070

AN - SCOPUS:0028969272

VL - 22

SP - 154

EP - 159

JO - Journal of Hepatology, Supplement

JF - Journal of Hepatology, Supplement

SN - 0169-5185

IS - 1

ER -